Case Reports in Radiology

Case Reports in Radiology / 2014 / Article

Case Report | Open Access

Volume 2014 |Article ID 614347 | 6 pages | https://doi.org/10.1155/2014/614347

Multimodality Imaging Evaluation of an Uncommon Entity: Esophageal Heterotopic Pancreas

Academic Editor: C. Preul
Received01 Nov 2013
Accepted03 Feb 2014
Published11 Mar 2014

Abstract

A 25-year-old male was referred to the Radiology Department with new onset of right upper quadrant and epigastric abdominal pain. He had no past medical or surgical history. Physical exam was unremarkable. The patient underwent computed tomography (CT), fluoroscopic upper gastrointestinal (GI) evaluation, endoscopic ultrasound (EUS), and positron emission tomography (PET) evaluation, revealing the presence of a heterogeneous esophageal mass. In light of imaging findings and clinical workup, the patient was ultimately referred for thorascopic surgery. Surgical findings and histology confirmed the diagnosis of esophageal heterotopic pancreas.

1. Introduction

Heterotopic pancreas is defined as histologically proven normal pancreatic tissue that lacks anatomic, vascular, and ductal continuity with the orthotopic pancreas. Other common names for this entity include ectopic, aberrant, or accessory pancreas [1]. Heterotopic pancreas is most commonly discovered incidentally in the abdomen. However, intrathoracic location in association with the esophagus is rare, with only 15 cases reported in the English literature [2]. Here, we report a very rare case of esophageal heterotopic pancreas discovered after extensive radiologic investigation and pathologic correlation.

2. Case Presentation

A 25-year-old male with no significant past medical or surgical history presented with 2 weeks of moderate to severe right upper quadrant and epigastric abdominal pain. His pain was occasionally associated with heavy exercise and meals. Physical exam and clinical laboratory findings were unremarkable.

Initial radiographic evaluation demonstrated abnormal frontal and lateral chest images (Figures 1(a) and 1(b)). Following the descending aortic shadow inferiorly, a subtle opacity with a rounded contour was identified superior to the gastroesophageal (GE) junction. This was not well appreciated on the lateral view, possibly due to the overlapping shadow of the posterior mediastinum. These radiographic findings were suspicious for a retrocardiac posterior mediastinal mass.

Given the vague right upper quadrant and epigastric symptoms, a right upper quadrant ultrasound (US) was performed. However, the exam was noncontributory. Continued suspicion for a mass prompted further evaluation with computed tomography (CT) (Figures 2(a), 2(b), 2(c), and 2(d)). A 4.4 × 3.7 × 3.2 cm paraesophageal mass was demonstrated just superior to the gastroesophageal (GE) junction. The mass consisted of a peripheral rim of heterogeneous tissue (1 cm in thickness) with moderate enhancement and a central ovoid region of lower density (average 19 Hounsfield units). No local or distant lymphadenopathy was present. No discrete fistulous esophageal connection was identified; however, the mass demonstrated broad abutment along the distal esophagus with evidence of mild contouring and adjacent luminal irregularity and narrowing. The imaging characteristics (size, attenuation, contours, and enhancement) were most consistent with a subepithelial mass, though the tissue of origin remained uncertain. Given the patient demographics, tumor size, and CT appearance, a gastrointestinal stromal tumor was initially favored. Due to the distal esophageal location, heterotopic pancreas was not initially considered in the differential diagnosis. Subsequently, esophagogastroduodenoscopy (EGD) visualized multiple small holes in the esophageal wall overlying the mass, thought to represent fistulous tracts (Figures 3(a) and 3(b)). Biopsies in this region were performed; however, they were ultimately deemed nondiagnostic. Endoscopic ultrasound (EUS) revealed a well-circumscribed heterogeneous hypoechoic subepithelial mass abutting the aorta (Figure 4(a)). Though the EGD and EUS findings were nonspecific, the apparent fistulous tracts raised the suspicion of abnormal connection with an airway or possibly with another subjacent anatomic structure.

An upper gastrointestinal (UGI) double contrast fluoroscopic exam was performed to further characterize the subepithelial mass and to investigate the apparent fistulas. Upright frontal and left anterior oblique low-dose fluoroscopic images demonstrated classic UGI findings of a subepithelial mass: a smooth-surfaced, hemispheric lesion forming obtuse angles with the adjacent luminal contour [3] (Figures 5(a) and 5(b)). Interestingly, the UGI series also demonstrated trace slivers of extraluminal contrast, presumably representing extension into the tumor proper. Notably, there was no evidence of contrast extravasation within the airways, subpleural space, or lung parenchyma.

Despite extensive imaging and numerous biopsy attempts, the differential diagnosis remained broad and included both benign and malignant processes. Considering the possibility of malignancy, a positron emission tomography (PET) scan was performed utilizing fluorine-18 fluorodeoxyglucose (F-18 FDG). The mass demonstrated increased FDG avidity, with a standardized uptake value average of 6.0 and maximally of 10.0 (Figures 6(a), 6(b), 6(c), and 6(d)). The remainder of the study demonstrated physiologic uptake. The associated FDG uptake immediately raised concern for a neoplasm. However, FDG is not a cancer-specific agent and uptake can be seen with inflammatory, infectious, and neoplastic processes. Moreover, normal uptake of FDG commonly occurs in various sites throughout the body. The gastroesophageal junction region is known to occasionally show normal uptake [4].

In the absence of a tissue diagnosis or diagnostic imaging, optimal management remained unclear. In order to obtain definitive tissue diagnosis, left-sided video-assisted thoracic surgery was performed which revealed a soft, mobile, cyst-like structure upon direct visualization. Pathologic analysis demonstrated presence of pancreatic heterotopia with overlying unremarkable squamoglandular mucosa (Figures 7(a) and 7(b)). The pathologic findings excluded the possibility of metaplasia, dysplasia, or malignancy.

3. Management

Management of this entity has varied from observation to radical surgery, such as Ivor-Lewis esophagectomy. As evidenced by our case, preoperative diagnosis is often difficult and is usually determined once the specimen is removed in its entirety. After weighing the severity of symptoms and the possibility for malignant potential, surgical resection of heterotopic pancreas is often the preferred management [5]. While the lesion appeared relatively benign under direct visualization, complete surgical resection was considered appropriate in our case.

4. Follow-Up

The patient had an uneventful surgical recovery. A swallow study performed on postoperative day three showed no evidence of contrast extravasation (images not shown). He had an uneventful hospital course, and the patient returned for two-month clinic follow-up without surgical complications and self-reported resolution of the epigastric pain.

5. Discussion

Heterotopic pancreas, in any location, is found in 0.6% to 13.6% of autopsies and 0.2% to 0.5% of abdominal operations [6]. There is a slight predilection to occur in males, generally in the fourth to the sixth decades of life. Esophageal heterotopic pancreas is a rare entity, with a comprehensive literature review revealing only fifteen cases reported to date.

Our case demonstrated a classic presentation of subepithelial mass on UGI fluoroscopic evaluation. Subepithelial masses, previously termed “submucosal” masses, are defined as masses covered with normal appearing submucosa. “Subepithelial” is the preferred term because these masses can arise from any layer of the gastrointestinal (GI) wall (i.e., intramural). In addition, other intra-abdominal structures and masses (i.e., extramural) can produce extrinsic impressions visible on imaging [7]. The PET CT findings were somewhat confounding, but the noted FDG uptake likely represented a localized inflammatory process, consistent with the patient’s symptomatology.

Although typically asymptomatic, esophageal heterotopic pancreas has been associated with epigastric pain, dysphagia, obstruction, and upper gastrointestinal bleeding [8]. As a normal eutopic pancreatic tissue, heterotopic pancreatic tissue specimens can contain pancreatic acini, ducts, and occasionally islets of Langerhans [9]. Pancreatic acini make up the majority of normal pancreatic tissue and are responsible for the exocrine function of the organ. Acinar cells contain membrane-bound zymogen granules, rich in digestive enzymes [10]. This enzyme-rich serous fluid is then secreted into the duct lumen. Acinar cells are normally pyramidally shaped epithelial cells that are radially oriented around a central lumen. In retrospect, the central hypodensity seen on CT could have represented a rudimentary ductal structure.

The normal pancreas arises from fusion of the ventral and dorsal outpouchings of the foregut [10]. Although the pathogenesis of heterotopic pancreas has not been definitively established, a current theory postulates that the embryologic origin involves abnormal detachment of one or more branching pancreatic buds during embryonic rotation. Following this theory, it is not surprising that heterotopic pancreas most commonly occurs near the stomach; specifically, in the prepyloric region along the greater curvature [1]. Complications of heterotopic pancreas include pseudocyst formation, pancreatitis, and both benign and malignant transformation [11]. A small case series reported malignancy in two out of nine observed cases of esophageal heterotopic pancreas [6]. Potential neoplasms associated with ectopic pancreas include adenocarcinomas, anaplastic cancers, islet cell adenomas, cystadenocarcinomas, and solid and papillary epithelial tumors [6]. Though exceedingly rare, our case of esophageal heterotopic pancreas displayed an excellent review of several classic radiographic findings while emphasizing the importance of maintaining a broad differential diagnosis.

Abbreviations

UGI:Upper gastrointestinal exam
GI:Gastrointestinal
EGD:Esophagogastroduodenoscopy
PET:Positron emission tomography
CT:Computed tomography
US:Ultrasound
GE:Gastroesophageal
SUV:Standardized uptake value
F-18 FDG:Fluorine-18 fluorodeoxyglucose
MIP:Maximal intensity projection.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

The views expressed in this paper are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. Government. The authors are military service members. This work was prepared as part of their official duties. Title 17, USC, § 105 provides that “copyright protection under this title is not available for any work of the United States Government.” Title 17, USC, § 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.

References

  1. J. Y. Kim, J. M. Lee, K. W. Kim et al., “Ectopic pancreas: CT findings with emphasis on differentiation from small gastrointestinal stromal tumor and leiomyoma,” Radiology, vol. 252, no. 1, pp. 92–100, 2009. View at: Publisher Site | Google Scholar
  2. S. Gananadha and D. R. Hunt, “A unique case of pancreatitis and retention cyst in esophageal heterotopic pancreas,” Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 15, no. 6, pp. 345–347, 2005. View at: Publisher Site | Google Scholar
  3. S. E. Rubesin, M. S. Levine, and I. Laufer, “Double-contrast upper gastrointestinal radiography: a pattern approach for diseases of the stomach,” Radiology, vol. 246, no. 1, pp. 33–48, 2008. View at: Publisher Site | Google Scholar
  4. S. Ahmad Sarji, “Physiological uptake in FDG PET simulating disease,” Biomedical Imaging and Intervention Journal, vol. 2, no. 4, article e59, 2006. View at: Publisher Site | Google Scholar
  5. C. F. Eisenberger, A. Gocht, W. T. Knoefel et al., “Heterotopic pancreas—clinical presentation and pathology with review of the literature,” Hepato-Gastroenterology, vol. 51, no. 57, pp. 854–858, 2004. View at: Google Scholar
  6. R. T. Temes, M. J. Menen, M. S. Davis, S. B. Pett Jr., and J. A. Wernly, “Heterotopic pancreas of the esophagus masquerading as Boerhaave's syndrome,” Annals of Thoracic Surgery, vol. 69, no. 1, pp. 259–261, 2000. View at: Publisher Site | Google Scholar
  7. N. K. Lee, S. Kim, G. H. Kim et al., “Hypervascular Subepithelial gastrointestinal masses: CT-pathologic correlation,” Radiographics, vol. 30, no. 7, pp. 1915–1934, 2010. View at: Publisher Site | Google Scholar
  8. M. Shalaby, M. L. Kochman, and G. R. Lichtenstein, “Heterotopic pancreas presenting as dysphagia,” American Journal of Gastroenterology, vol. 97, no. 4, pp. 1046–1049, 2002. View at: Publisher Site | Google Scholar
  9. C. M. Qualia, T. M. Rossi, and A. Ullah, “Heterotopic pancreatic tissue found in the esophagus of a 14-year-old girl,” Gastroenterology and Hepatology, vol. 3, no. 12, pp. 939–940, 2007. View at: Google Scholar
  10. S. L. Robbins, V. Kumar, A. K. Abbas, and R. S. Cotran, Fausto N. Robbins and Cotran Pathologic Basis of Disease, WB Saunders Company, 2010.
  11. G. E. Persson and P. T. Boiesen, “Cancer of aberrant pancreas in jejunum. Case report,” Acta Chirurgica Scandinavica, vol. 154, no. 10, pp. 599–601, 1988. View at: Google Scholar

Copyright © 2014 Takman Mack et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1130 Views | 552 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.